RohteshSMehtaMD

PubMed

• 22 citations
  Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation.
  Amanda Olson, Ruitao Lin, David Marin, Hind Rafei, Mustafa Bdaiwi
  Journal of Clinical Oncology. 2021-04-30
• 1140 citations
  Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
  Enli Liu, David Marin, Pinaki P. Banerjee, Homer A. Macapinlac, Philip A. Thompson
  The New England Journal of Medicine. 2020-02-05
• 18 citations
  Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation.
  Betul Oran, Richard E. Champlin, Feng Wang, Tomoyuki Tanaka, Rima M. Saliba
  Leukemia. 2021-06-16

Journal Articles

• Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction Drugs  
  Krina Patel, Rohtesh Mehta, Donna M Weber, Sheeba K Thomas, Nina Shah, Hans C Lee, Elisabet E Manasanch, Muzaffar H Qazilbash, Qaiser Bashir, Simrit Parmar, Robert Z O..., Nature

Abstracts/Posters

• Clinical Relevance of MYC/BCL2 and Cell of Origin in Patients with Relapsed Diffuse Large B-Cell Lymphoma Treated with Autologous Stem Cell Transplantation
  Rohtesh S. Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Post-Transplant Cyclophosphamide (PT-Cy) Based Haploidentical Cell Transplantation (Haplo) Versus Rabbit Anti-Thymocyte Globulin (r-ATG) Based HLA Matched Unrelated Do...
  Rohtesh S. Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Donor Clonal Hematopoiesis Increases Risk of Acute Graft Versus Host Disease after Matched Related Transplantation in AML and MDS Patients
  Rohtesh S. Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Blinatumomab Is Well Tolerated Maintenance Therapy Following Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
  Rohtesh Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Myeloablative Fractionated Busulfan Conditioning Regimen in Older Patients: Results of a Phase II Study
  Rohtesh S. Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Allogeneic Transplantation for Myelodysplastic Syndrome in Adults over 50 Years Old Using Reduced Intensity/Non-Myeloablative Conditioning: Haploidentical Relative Ver...
  Rohtesh S. Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Reduced Severe aGVHD and Improved Survival Using Post Transplant Cyclophosphamide/Tacrolimus/Methotrexate Graft Versus Host Disease Prophylaxis in AML Patients Receivi...
  Rohtesh S. Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Somatic Mutations Improve Risk Classification By Cytogenetic Abnormalities in Patients with Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation
  Rohtesh Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Optimal Conditioning for Older Patients with Acute Myeloid Leukemia (AML) Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Propensity Score Analysis
  Rohtesh S. Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Outcomes of Lenalidomide Retreatment with Novel Triplet Regimens in Multiple Myeloma Patients Progressing on Lenalidomide-Based Maintenance Therapy: A Single Center Re...
  Rohtesh S. Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Nonmyeloablative Allogeneic Transplantation (NMAT) Confers an Overall Survival Benefit with Similar Non-Relapse Mortality When Compared to Autologous Stem Transplantat...
  Rohtesh S. Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Randomized Study of Fludarabine-Clofarabine Vs Fludarabine Alone Combined with Busulfan and Allogeneic Hematopoietic Transplantation for AML and MDS
  Rohtesh Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Allogeneic Hematopoietic Cell Transplantation May Improve Long-Term Outcomes in Patients with Ph-like Acute Lymphoblastic Leukemia with CRLF2 Overexpression
  Rohtesh S. Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation after Double Cord Blood Transplantation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018